CONDUALNINE Trademark

Trademark Overview


On Friday, August 20, 2021, a trademark application was filed for CONDUALNINE with the United States Patent and Trademark Office. The USPTO has given the CONDUALNINE trademark a serial number of 90894917. The federal status of this trademark filing is REGISTERED as of Tuesday, September 26, 2023. This trademark is owned by Akeso Pharmaceuticals, Inc.. The CONDUALNINE trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; vaccines; biochemical medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; chemico-pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; biological preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia for medical purposes; hemoglobin; medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia for human purposes; Drugs, namely, pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia for human purposes; hematogen for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; inje...

Retail store services and wholesale store services featuring medicines; Retail store services and wholesale stole services featuring pharmaceutical preparations; Retail store services and wholesale store services featuring sanitary preparations; Retail store services and wholesale store services featuring medical supplies; advertising and publicity services; publicity; organization of exhibitions and events for commercial or advertising purposes; marketing the goods and services of others by providing hyperlinks to websites of others; demonstration of goods; conducting market studies; business appraisals; business investigations; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; import-export agency services

Technological research in the field of medicines and pharmaceutical preparations; research and development of new products for others; scientific laboratory services; product quality testing; conducting technical project studies in the nature of research in the field of pharmaceutical studies; chemical research; chemistry services, namely, research in the field of chemistry; chemical analysis; biological research; bacteriological research; medical and scientific research, namely, conducting clinical trials for others; scientific research
condualnine

General Information


Serial Number90894917
Word MarkCONDUALNINE
Filing DateFriday, August 20, 2021
Status700 - REGISTERED
Status DateTuesday, September 26, 2023
Registration Number7172242
Registration DateTuesday, September 26, 2023
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 14, 2023

Trademark Statements


Description of MarkThe mark consists of the stylized word "CONDUALNINE".
Goods and ServicesPharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; vaccines; biochemical medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; chemico-pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; biological preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia for medical purposes; hemoglobin; medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia for human purposes; Drugs, namely, pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia for human purposes; hematogen for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; injectable medicinal solutions for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia
Goods and ServicesRetail store services and wholesale store services featuring medicines; Retail store services and wholesale stole services featuring pharmaceutical preparations; Retail store services and wholesale store services featuring sanitary preparations; Retail store services and wholesale store services featuring medical supplies; advertising and publicity services; publicity; organization of exhibitions and events for commercial or advertising purposes; marketing the goods and services of others by providing hyperlinks to websites of others; demonstration of goods; conducting market studies; business appraisals; business investigations; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; import-export agency services
Goods and ServicesTechnological research in the field of medicines and pharmaceutical preparations; research and development of new products for others; scientific laboratory services; product quality testing; conducting technical project studies in the nature of research in the field of pharmaceutical studies; chemical research; chemistry services, namely, research in the field of chemistry; chemical analysis; biological research; bacteriological research; medical and scientific research, namely, conducting clinical trials for others; scientific research

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 7, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, October 7, 2021
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 7, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAkeso Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGuangzhou, Guangdong 510799
CN

Party NameAkeso Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGuangzhou, Guangdong 510799
CN

Party NameAkeso Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGuangzhou, Guangdong 510799
CN

Trademark Events


Event DateEvent Description
Monday, February 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 26, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 26, 2023REGISTERED-PRINCIPAL REGISTER
Friday, August 18, 20231(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, June 28, 2023NOTICE OF ALLOWANCE CANCELLED
Friday, August 18, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 28, 2023TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, May 9, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 25, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 25, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 24, 2023ASSIGNED TO LIE
Wednesday, November 23, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 24, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 24, 2022NON-FINAL ACTION E-MAILED
Tuesday, May 24, 2022NON-FINAL ACTION WRITTEN
Monday, May 23, 2022ASSIGNED TO EXAMINER
Thursday, October 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 24, 2021NEW APPLICATION ENTERED